Last reviewed · How we verify

NCT05940103

Augmented Reality (AR) Hong Kong

Not yet recruiting NA Last updated 19 September 2024
What this trial tests

NA trial testing Augmented Reality (AR) in Educational Problems in 32 participants. Not yet recruiting.

Timeline
1 November 2024
Primary endpoint
31 July 2025
31 July 2025

Quick facts

Lead sponsorStanford University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment32
Start date1 November 2024
Primary completion31 July 2025
Estimated completion31 July 2025
Sites2 locations across Hong Kong, United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

Adults 18 to 99, any sex, with Educational Problems. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an international, collaborative study evaluating the non-technical skills (NTS) of anesthesiology residents. The goal is to explore the capability of performing a remote, international AR simulation for the purpose of assessing PALS during a medical crisis. Simulation experts in the United States will facilitate the AR simulations with anesthesiology residents in Hong Kong. The medical simulation itself is grounded in traditional best practices in accordance with the American Heart Association.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Augmented Reality (AR)

Trials testing the same drug.

Other recruiting trials for Educational Problems

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05940103.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing